p53 regulates the transcription of its Delta133p53 isoform through specific response elements contained within the TP53 P2 internal promoter
- PMID: 20190805
- DOI: 10.1038/onc.2010.26
p53 regulates the transcription of its Delta133p53 isoform through specific response elements contained within the TP53 P2 internal promoter
Abstract
The tumor suppressor p53 protein is activated by genotoxic stress and regulates genes involved in senescence, apoptosis and cell-cycle arrest. Nine p53 isoforms have been described that may modulate suppressive functions of the canonical p53 protein. Among them, Delta133p53 lacks the 132 proximal residues and has been shown to modulate p53-induced apoptosis and cell-cycle arrest. Delta133p53 is expressed from a specific mRNA, p53I4, driven by an alternative promoter P2 located between intron 1 and exon 5 of TP53 gene. Here, we report that the P2 promoter is regulated in a p53-dependent manner. Delta133p53 expression is increased in response to DNA damage by doxorubicin in p53 wild-type cell lines, but not in p53-mutated cells. Chromatin immunoprecipitation and luciferase assays using P2 promoter deletion constructs indicate that p53 binds functional response elements located within the P2 promoter. We also show that Delta133p53 does not bind specifically to p53 consensus DNA sequence in vitro, but competes with wild-type p53 in specific DNA-binding assays. Finally, we report that Delta133p53 counteracts p53-dependent growth suppression in clonogenic assays. These observations indicate that Delta133p53 is a novel target of p53 that may participate in a negative feedback loop controlling p53 function.
Similar articles
-
A SNP in the flt-1 promoter integrates the VEGF system into the p53 transcriptional network.Proc Natl Acad Sci U S A. 2006 Jan 31;103(5):1406-11. doi: 10.1073/pnas.0508103103. Epub 2006 Jan 23. Proc Natl Acad Sci U S A. 2006. PMID: 16432214 Free PMC article.
-
Additive effect between NF-kappaB subunits and p53 protein for transcriptional activation of human p53 promoter.Oncogene. 2000 Sep 28;19(41):4787-94. doi: 10.1038/sj.onc.1203831. Oncogene. 2000. PMID: 11032029
-
Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site.Oncogene. 2000 Mar 30;19(14):1735-43. doi: 10.1038/sj.onc.1203489. Oncogene. 2000. PMID: 10777207
-
p53 isoforms gain functions.Oncogene. 2010 Sep 16;29(37):5113-9. doi: 10.1038/onc.2010.266. Epub 2010 Jul 12. Oncogene. 2010. PMID: 20622898 Review.
-
[Tumor suppressor gene p53].Nihon Rinsho. 1996 Apr;54(4):960-4. Nihon Rinsho. 1996. PMID: 8920657 Review. Japanese.
Cited by
-
Δ113p53/Δ133p53: survival and integrity.Oncotarget. 2015 Jun 10;6(16):13850-1. doi: 10.18632/oncotarget.4371. Oncotarget. 2015. PMID: 26116838 Free PMC article. No abstract available.
-
p53 Isoforms as Cancer Biomarkers and Therapeutic Targets.Cancers (Basel). 2022 Jun 27;14(13):3145. doi: 10.3390/cancers14133145. Cancers (Basel). 2022. PMID: 35804915 Free PMC article. Review.
-
Adaptive homeostasis and the p53 isoform network.EMBO Rep. 2021 Dec 6;22(12):e53085. doi: 10.15252/embr.202153085. Epub 2021 Nov 15. EMBO Rep. 2021. PMID: 34779563 Free PMC article. Review.
-
Canonical and non-canonical functions of p53 isoforms: potentiating the complexity of tumor development and therapy resistance.Cell Death Dis. 2024 Jun 12;15(6):412. doi: 10.1038/s41419-024-06783-7. Cell Death Dis. 2024. PMID: 38866752 Free PMC article. Review.
-
p53 Family: Role of Protein Isoforms in Human Cancer.J Nucleic Acids. 2012;2012:687359. doi: 10.1155/2012/687359. Epub 2011 Oct 9. J Nucleic Acids. 2012. PMID: 22007292 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous